Reasons to Retain DexCom (DXCM) Stock in Your Portfolio Now

DexCom, Inc. (DXCM) is well-poised for growth in the coming quarters, backed by its strong product portfolio. A robust first-quarter 2024 performance, along with a series of favorable coverage decisions, is expected to contribute further. However, risks related to stiff competition persist.This current Zacks Rank #3 (Hold) company’s shares have risen 6.3% year to date compared with the industry’s 10% growth. The S&P 500 Index has increased 11.5% in the same time frame.DXCM, a renowned medical device company ...